Department of Education and Obesity Treatment and Metabolic Disorders; Poznan University of Medical Sciences
Poznan, 60-569, Poland
NCT Number: NCT03444207
The aim of this study was to compare the effects of three months' endurance training and three months' endurance-strength training on inflammatory markers in women with abdominal obesity.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Poznan, 60-569, Poland
Study patients. Written informed consent was obtained from all subjects. The study meets the standards of the Declaration of Helsinki in its revised version of 1975 and its amendments of 1983, 1989, and 1996.
Study design. The study was designed as a prospective randomized trial. Subjects were randomly divided into two groups, A and B, using a randomization list. Both groups performed three month of physical training. Group A underwent endurance training, while group B performed endurance-strength training. Aside from the training, all subjects were instructed to maintain the physical activity and diet that they had been practicing so far. At baseline and after three months of physical training, blood samples for laboratory analyses were taken, anthropometric measurements were performed for both groups.
Intervention. The exercise program lasted three months, with three sessions per week. Women in both groups participated in a total of 36 training sessions. The women in group A underwent endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA). Exercise sessions consisted of a five-minute warm-up (stretching exercise) at low intensity (50%-60% of maximum heart rate), a 45-minute exercise (at 50%-80% of maximum heart rate), five minutes of cycling without a load, and five minutes of closing stretching and breathing exercise of low intensity. Group B performed endurance-strength exercise consisting of a five-minute warm-up (stretching exercises) of low intensity (50%-60% of maximum heart rate), a strength component, an endurance component, 5 minutes cycling without a load, and a 5 minutes closing stretching and breathing exercise of low intensity. The 20-minute-long strength component was performed using a neck barbell and a gymnastic ball. Directly after the strength exercise, the women took part in a 25-minute endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA) at 50%-80% of maximum heart rate. Both the endurance and endurance-strength training were comparable in exercise volume; the only difference was the nature of the effort.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The women in group A underwent endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA). Exercise sessions consisted of a five-minute warm-up (stretching exercise) at low intensity (50%-60% of maximum heart rate), a 45-minute exercise (at 50%-80% of maximum heart rate), five minutes of cycling without a load, and five minutes of closing stretching and breathing exercise of low intensity.
Group B performed endurance-strength exercise consisting of a five-minute warm-up (stretching exercises) of low intensity (50%-60% of maximum heart rate), a strength component, an endurance component, 5 minutes cycling without a load, and a 5 minutes closing stretching and breathing exercise of low intensity. The 20-minute-long strength component was performed using a neck barbell and a gymnastic ball. Directly after the strength exercise, the women took part in a 25-minute endurance exercise on cycle ergometers (Schwinn Evolution, Schwinn Bicycle Company, Boulder, Colorado, USA) at 50%-80% of maximum heart rate.
Time frame: At baseline
Serum concentration of C-reactive protein at baseline
Time frame: after three months of physical training
Serum concentration of C-reactive protein after three months of physical training
Time frame: at baseline
Serum concentration of tumor necrosis factor alpha at baseline
Time frame: after three months of physical training
Serum concentration of tumor necrosis factor alpha after three months of physical training
Time frame: At baseline
Serum concentration of soluble receptor 2 of TNF alpha at baseline
Time frame: after three months of physical training
Serum concentration of soluble receptor 2 of TNF alpha after three months of physical training
Time frame: At baseline
Serum concentration of interleukin 6 at baseline
Time frame: after three months of physical training
Serum concentration of interleukin 6 after three months of physical training
Time frame: At baseline
Serum concentration of interleukin 1 at baseline
Time frame: after three months of physical training
Serum concentration of interleukin 1 after three months of physical training
Time frame: At baseline
Serum concentration of visfatin at baseline
Time frame: after three months of physical training
Serum concentration of visfatin after three months of physical training
Time frame: At baseline
Body mass at baseline
Time frame: after three months of physical training
Body mass after three months of physical training
Time frame: At baseline
Body height at baseline
Time frame: after three months of physical training
Body height after three months of physical training
Poznan University of Medical Sciences
Other
Acronym: ENDOFIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06169137
Behavior, Body Weight
Bethesda, Maryland, United States
View Trial DetailsNCT06186102
Arterial Occlusive Diseases, Arteriosclerosis
Aarhus, Jutland, Denmark
View Trial DetailsNCT05327868
Body Weight, Dietary Fat
New Brunswick, New Jersey, United States
View Trial DetailsNCT06911879
Body Weight, Caloric Restriction
Amman, Jordan
View Trial Details